1-(1H-benzimidazol-2-yl)thiourea |
Co(II)-form of enzyme, 50% inhibition at 0.0089 mM |
Escherichia coli |
|
1-benzyl-2-(1,3-thiazol-4-yl)-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00046 mM |
Escherichia coli |
|
1-benzyl-2-pyridin-2-yl-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00099 mM |
Escherichia coli |
|
1-methyl-2-(1,3-thiazol-4-yl)-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00050 mM |
Escherichia coli |
|
2-(1,3-thiazol-4-yl)-1H-benzimidazol-5-amine |
Co(II)-form of enzyme, 50% inhibition at 0.00339 mM |
Escherichia coli |
|
2-(1,3-thiazol-4-yl)-1H-imidazo(4,5-c)pyridine |
Co(II)-form of enzyme, 50% inhibition at 0.00172 mM |
Escherichia coli |
|
2-(1H-benzimidazol-2-ylamino)pyridin-3-ol |
Co(II)-form of enzyme, 50% inhibition at 0.00078 mM |
Escherichia coli |
|
2-(3H-pyrrol-5-yl)-1H-imidazo(4,5-b)pyridine |
Co(II)-form of enzyme, 50% inhibition at 0.000078 mM |
Escherichia coli |
|
2-pyridin-2-yl-1H-benzimidazol-5-amine |
Co(II)-form of enzyme, 50% inhibition at 0.0097 mM |
Escherichia coli |
|
2-pyridin-2-yl-1H-benzimidazole-5-carbonitrile |
Co(II)-form of enzyme, 50% inhibition at 0.00043 mM |
Escherichia coli |
|
2-pyridin-2-yl-1H-imidazo(4,5-b)pyrazine |
Co(II)-form of enzyme, 50% inhibition at 0.00024 mM |
Escherichia coli |
|
2-pyridin-2-yl-1H-imidazo(4,5-b)pyridine |
Co(II)-form of enzyme, 50% inhibition at 0.00011 mM |
Escherichia coli |
|
2-pyridin-2-yl-1H-imidazo(4,5-c)pyridine |
Co(II)-form of enzyme, 50% inhibition at 0.00055 mM |
Escherichia coli |
|
5,6-dimethyl-2-pyridin-2-yl-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00243 mM |
Escherichia coli |
|
5-chloro-2-(1,3-thiazol-4-yl)-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00515 mM |
Escherichia coli |
|
5-chloro-2-pyridin-2-yl-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00169 mM |
Escherichia coli |
|
5-fluoro-2-(1,3-thiazol-4-yl)-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00431 mM |
Escherichia coli |
|
5-fluoro-2-pyridin-2-yl-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00151 mM |
Escherichia coli |
|
5-methyl-2-(1,3-thiazol-4-yl)-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00716 mM |
Escherichia coli |
|
5-methyl-2-pyridin-2-yl-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00209 mM |
Escherichia coli |
|
5-nitro-2-(1,3-thiazol-4-yl)-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00122 mM |
Escherichia coli |
|
5-nitro-2-pyridin-2-yl-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00016 mM |
Escherichia coli |
|
5-tert-butyl-2-(1,3-thiazol-4-yl)-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00391 mM |
Escherichia coli |
|
5-tert-butyl-2-pyridin-2-yl-1H-benzimidazole |
Co(II)-form of enzyme, 50% inhibition at 0.00260 mM |
Escherichia coli |
|
6-(1H-benzimidazol-2-ylamino)pyridin-2-ol |
Co(II)-form of enzyme, 50% inhibition at 0.00134 mM |
Escherichia coli |
|
8-pyridin-2-yl-7H-purine |
Co(II)-form of enzyme, 50% inhibition at 0.00038 mM |
Escherichia coli |
|
fumagillin |
Co(II)-form of enzyme, 50% inhibition at 0.000915 mM |
Escherichia coli |
|
additional information |
thiabendazole and its derivatives are potent inhibitors in vitro, but fail to inhibit in vivo because they bind as Co2+-complexes to H79, thus blocking the active site of enzyme. In the in vitro assay the metal ion concentration is considerably higher than under in vivo conditions |
Escherichia coli |
|
N-1,3-thiazol-2-yl-1H-benzimidazol-2-amine |
Co(II)-form of enzyme, 50% inhibition at 0.00054 mM |
Escherichia coli |
|
N-1,3-thiazol-2-ylpyridine-2-carboxamide |
Co(II)-form of enzyme, 50% inhibition at 0.000063 mM, binds to an additional Co2+ ion at the entrance of the active site |
Escherichia coli |
|
N-pyrazin-2-yl-1H-benzimidazol-2-amine |
Co(II)-form of enzyme, 50% inhibition at 0.0046 mM |
Escherichia coli |
|
N-pyridin-2-yl-1H-benzimidazol-2-amine |
Co(II)-form of enzyme, 50% inhibition at 0.00057 mM |
Escherichia coli |
|
phenyl(2-(1,3-thiazol-4-yl)-1H-benzimidazol-5-yl)methanone |
Co(II)-form of enzyme, 50% inhibition at 0.00240 mM |
Escherichia coli |
|
phenyl(2-pyridin-2-yl-1H-benzimidazol-5-yl)methanone |
Co(II)-form of enzyme, 50% inhibition at 0.00040 mM |
Escherichia coli |
|
thiabendazole |
Co(II)-form of enzyme, 50% inhibition at 0.00047 mM, binds to an additional Co2+ ion at the entrance of the active site |
Escherichia coli |
|